157 related articles for article (PubMed ID: 3121506)
1. Fifth component of complement (C5)-derived high-molecular-weight macrophage chemotactic factor in normal guinea pig serum.
Kukita I; Yamamoto T; Kawaguchi T; Kambara T
Inflammation; 1987 Dec; 11(4):459-79. PubMed ID: 3121506
[TBL] [Abstract][Full Text] [Related]
2. The chemotactic activity of normal and complement-activated serum as measured by the leading-front method using a Boyden chamber.
Håkansson L; Venge P
Scand J Immunol; 1984 Jan; 19(1):63-73. PubMed ID: 6367020
[TBL] [Abstract][Full Text] [Related]
3. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
[TBL] [Abstract][Full Text] [Related]
4. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
5. A new biological activity of the complement factor H: identification of the precursor of the major macrophage-chemotactic factor in delayed hypersensitivity reaction sites of guinea pigs.
Imamura T; Ohtsuka H; Matsushita M; Tsuruta J; Okada H; Kambara T
Biochem Biophys Res Commun; 1992 Jun; 185(2):505-9. PubMed ID: 1535192
[TBL] [Abstract][Full Text] [Related]
6. The chemical mediation of delayed hypersensitivity skin reactions: III. Purification and characterization of a precursor protein for macrophage-chemotactic factor in normal guinea pig plasma.
Ueda K; Kawaguchi T; Okamoto T; Kambara T
Am J Pathol; 1982 Sep; 108(3):291-8. PubMed ID: 7114165
[TBL] [Abstract][Full Text] [Related]
7. Factor XIII-dependent generation of 5th complement component(C5)-derived monocyte chemotactic factor coinciding with plasma clotting.
Okamoto M; Yamamoto T; Matsubara S; Kukita I; Takeya M; Miyauchi Y; Kambara T
Biochim Biophys Acta; 1992 Jan; 1138(1):53-61. PubMed ID: 1346574
[TBL] [Abstract][Full Text] [Related]
8. The chemical mediation of delayed hypersensitivity skin reaction. II. Characterization of a macrophage-chemotactic factor from bovine gamma-globulin-induced skin reaction in guinea pigs.
Ueda K; Kambara T
Am J Pathol; 1978 Jul; 92(1):241-52. PubMed ID: 80137
[TBL] [Abstract][Full Text] [Related]
9. A C5-derived macrophage chemotactic factor from DNP-Ascaris extract-induced skin lesion in guinea pigs.
Hirashima M; Hirotsu Y; Yoshimura T; Hayashi H
Int Arch Allergy Appl Immunol; 1983; 70(4):361-7. PubMed ID: 6337964
[TBL] [Abstract][Full Text] [Related]
10. Interaction of chemotactic factors with human macrophages. Induction of transmembrane potential changes.
Gallin EK; Gallin JI
J Cell Biol; 1977 Oct; 75(1):277-89. PubMed ID: 410816
[TBL] [Abstract][Full Text] [Related]
11. The chemical mediation of delayed hypersensitivity skin reactions. IV. Activation of chemotactic factor precursor by a trypsin-like protease in guinea pig plasma.
Kawaguchi T; Ueda K; Yamamoto T; Kambara T
Am J Pathol; 1984 May; 115(2):307-15. PubMed ID: 6372498
[TBL] [Abstract][Full Text] [Related]
12. Macrophage accumulation in primary and transplanted tumors growing in C5-deficient B10.D2/oSn mice.
Evans R
Int J Cancer; 1980 Aug; 26(2):227-9. PubMed ID: 7203715
[TBL] [Abstract][Full Text] [Related]
13. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
[TBL] [Abstract][Full Text] [Related]
14. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
Kazmierowski JA; Gallin JI; Reynolds HY
J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
[TBL] [Abstract][Full Text] [Related]
15. A high molecular weight chemoattractant generated from C5 by ultracentrifugation of mouse serum without activation of complement.
Leonard EJ; Skeel A
Mol Immunol; 1983 Jun; 20(6):589-95. PubMed ID: 6410183
[TBL] [Abstract][Full Text] [Related]
16. Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.
Orr FW; Delikatny EJ; Mokashi S; Krepart GV; Stiver HG
Am J Pathol; 1983 Jan; 110(1):41-7. PubMed ID: 6185003
[TBL] [Abstract][Full Text] [Related]
17. Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.
Damerau B; Grünefeld E; Vogt W
Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):181-4. PubMed ID: 732894
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.
Gadek JE; Hunninghake GW; Zimmerman RL; Crystal RG
Am Rev Respir Dis; 1980 Apr; 121(4):723-33. PubMed ID: 6992662
[TBL] [Abstract][Full Text] [Related]
19. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.
Kew RR; Webster RO
J Clin Invest; 1988 Jul; 82(1):364-9. PubMed ID: 3392213
[TBL] [Abstract][Full Text] [Related]
20. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
Perez HD; Lipton M; Goldstein IM
J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
